GB1455552A - Pharmaceutical composition for topical administration - Google Patents

Pharmaceutical composition for topical administration

Info

Publication number
GB1455552A
GB1455552A GB955575A GB955575A GB1455552A GB 1455552 A GB1455552 A GB 1455552A GB 955575 A GB955575 A GB 955575A GB 955575 A GB955575 A GB 955575A GB 1455552 A GB1455552 A GB 1455552A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
topical administration
addition
neomycin
polyglycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB955575A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of GB1455552A publication Critical patent/GB1455552A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB955575A 1974-04-11 1975-03-21 Pharmaceutical composition for topical administration Expired GB1455552A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46025474A 1974-04-11 1974-04-11

Publications (1)

Publication Number Publication Date
GB1455552A true GB1455552A (en) 1976-11-17

Family

ID=23827960

Family Applications (1)

Application Number Title Priority Date Filing Date
GB955575A Expired GB1455552A (en) 1974-04-11 1975-03-21 Pharmaceutical composition for topical administration

Country Status (7)

Country Link
JP (1) JPS535729B2 (de)
AU (1) AU7776275A (de)
CA (1) CA1049409A (de)
DE (2) DE2504615C3 (de)
DK (1) DK143537C (de)
FR (1) FR2267107B1 (de)
GB (1) GB1455552A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140298A (en) * 1983-05-13 1984-11-28 Schering Corp Topical betamethasone dipropionate composition
WO2002022139A1 (en) * 2000-09-14 2002-03-21 Robert Theiler Intraarticular agent for the treatment of osteoarthritis

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3376957D1 (en) * 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
AU592065B2 (en) * 1984-10-09 1990-01-04 Dow Chemical Company, The Sustained release dosage form based on highly plasticized cellulose ether gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
ES2078256T3 (es) * 1990-04-05 1995-12-16 Knoll Ag Formula farmaceutica para uso topico que contiene diclofenaco sodico.
PL2366408T3 (pl) * 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017746B (de) * 1954-02-09 1957-10-17 Upjohn Co Verfahren zur Herstellung frei fliessender, nicht absetzender therapeutisch wirksamer Suspensionen
US3485915A (en) * 1966-04-22 1969-12-23 Revlon Thickened hydroxypropyl cellulose compositions
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DK135267A (de) * 1971-02-25

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2140298A (en) * 1983-05-13 1984-11-28 Schering Corp Topical betamethasone dipropionate composition
WO2002022139A1 (en) * 2000-09-14 2002-03-21 Robert Theiler Intraarticular agent for the treatment of osteoarthritis

Also Published As

Publication number Publication date
DE2515594A1 (de) 1975-10-30
CA1049409A (en) 1979-02-27
JPS535729B2 (de) 1978-03-01
DK147575A (de) 1975-10-12
DE2504615A1 (de) 1975-10-16
DK143537C (da) 1982-02-01
DK143537B (da) 1981-09-07
FR2267107B1 (de) 1978-07-28
AU7776275A (en) 1976-08-05
DE2504615B2 (de) 1977-07-14
DE2515594C3 (de) 1982-06-03
FR2267107A1 (de) 1975-11-07
JPS50132122A (de) 1975-10-20
DE2504615C3 (de) 1980-10-02
DE2515594B2 (de) 1978-12-07

Similar Documents

Publication Publication Date Title
CA1146070A (en) Topical triethylenetetramine-containing pharmaceutical compositions and methods of use
US4355028A (en) Composition for treating acne vulgaris
GB1455552A (en) Pharmaceutical composition for topical administration
KR890701109A (ko) 스테로이드 로숀
BE901328A (fr) Composition pharmaceutique a absorption reglee.
IE791593L (en) Acid addition salts of dipiperidinoandrostanes
GB2612201A (en) Topical disulfiram for treating viral infections
US3856954A (en) Topical steroid compositions
US3696195A (en) Stable aqueous steroid phosphate solutions
US3526698A (en) Stabilization of levo-3-(3,4-dihydroxyphenyl)-2-methylalanine with sodium bisulfite and sorbitol
GB2000025A (en) Nitroimidazole formulations
US3138528A (en) Stable, aqueous solutions of 21-phosphate esters of 21-hydroxy steroids
GB1481411A (en) Pharmaceutical compositions
US3415929A (en) Ophthalmic solution containing poly-1,3-beta-glucoside
US3524916A (en) Griseofulvin-ethylene glycol monosalicylate compositions
US4594359A (en) Pharmaceutical compositions
GB1463348A (en) Water-solubilised compositions
US5879711A (en) Stable antiandrogenic gel composition
DE2013039A1 (de) Arzneimitteltablette zur oralen Verabreichung
JP2893807B2 (ja) アズレン誘導体含有液剤
GB1125349A (en) Soluble salts of ellagic acid
JPH069430A (ja) 安定なリゾチーム配合点眼剤
IE37718L (en) Pharmaceutical compositions
ES8304429A1 (es) Un procedimiento para la preparacion de soluciones minerales acuosas estables de levonantradol y n-metil-levonantradol.
CN115137699A (zh) 一种增效防腐的右美托咪定鼻喷剂

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee